Fig. 3.
Fig. 3. Relapse rate following CD6-depleted BMT for acute leukemia. Kaplan-Meier estimated risk of disease relapse is depicted for patients with AML and ALL (logrank, P = .25).

Relapse rate following CD6-depleted BMT for acute leukemia. Kaplan-Meier estimated risk of disease relapse is depicted for patients with AML and ALL (logrank, P = .25).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal